Glucagon-Like Peptide-1 and Blood Pressure in Young and Healthy Adults from the General Population
Authors:
- Philipp KrisaiPKPhilipp Krisai
- Stefanie AeschbacherSAStefanie Aeschbacher
- Tobias SchoenTSTobias Schoen
- Matthias BossardMBMatthias Bossard
- Jan Gerrit van der StouweJSJan Gerrit van der Stouwe
- Laura DörigLDLaura Dörig
- John ToddJTJohn Todd
- Joel EstisJEJoel Estis
- Martin RischMRMartin Risch
- Lorenz RischLorenz Risch
- David ConenDCDavid Conen
- 1 February 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 65 (2) , 306-312
Abstract
Hypertension and diabetes mellitus are highly correlated, but the underlying mechanisms are only partly understood. Therefore, the aim of our study was to investigate the relationships between plasma levels of glucagon-like peptide-1, a key factor in the regulation of glucose homeostasis, and various blood pressure indices. Healthy adults aged 25 to 41 years were enrolled in a population-based study. Established cardiovascular disease, diabetes mellitus, or a body mass index >35 kg/m 2 were exclusion criteria. Fasting plasma glucagon-like peptide-1 levels as determined with a novel high-sensitive assay and ambulatory blood pressure data were available in 1479 participants not using antihypertensive treatment. Median age of our population was 38 years. Mean systolic and diastolic blood pressure across increasing glucagon-like peptide-1 quartiles were 120.6, 122.8, 123.2, and 124.9 mm Hg and 77.1, 78.7, 78.9, and 79.9 mm Hg, respectively. We found a linear relationship of glucagon-like peptide-1 with 24-hour ambulatory blood pressure after multivariable adjustment (β per 1 log-unit increase 2.01; 95% confidence interval, 1.02–3.00; P P =0.002 for diastolic blood pressure). In separate analyses, glucagon-like peptide-1 was significantly related to both awake (β per 1 log-unit increase 2.05; 1.02–3.09; P =0.0001 for systolic and 1.15; 0.35–1.96; P =0.005 for diastolic blood pressure) and asleep blood pressure (β per 1 log-unit increase 1.34; 0.26–2.42; P =0.01 for systolic and 1.05; 0.26–1.84; P =0.009 for diastolic blood pressure). In conclusion, plasma levels of glucagon-like peptide-1 are significantly associated with both systolic and diastolic blood pressure levels.Keywords
This publication has 35 references indexed in Scilit:
- Fasting Blood Glucose and the Risk of Stroke and Myocardial InfarctionCirculation, 2009
- Global burden of blood-pressure-related disease, 2001The Lancet, 2008
- Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health StudyEuropean Heart Journal, 2007
- Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort studyBMJ, 2007
- Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studiesBMJ, 2005
- The Prevalence of Prehypertension and Hypertension Among US Adults According to the New Joint National Committee GuidelinesArchives of internal medicine (1960), 2004
- Prevalence of Heart Disease and Stroke Risk Factors in Persons With Prehypertension in the United States, 1999-2000Archives of internal medicine (1960), 2004
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Impact of High-Normal Blood Pressure on the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 2001
- Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteriaThe Lancet, 1999